Related Experiment Videos
Cyclins and cdks in development and cancer: a perspective
Amit Deshpande1, Peter Sicinski, Philip W Hinds
1Department of Radiation Oncology, Molecular Oncology Research Institute, Tufts-New England Medical Center, Boston, MA 02111, USA.
Oncogene
|April 20, 2005
Summary
Cancer cells exhibit uncontrolled proliferation due to dysregulated cell cycle control, bypassing normal growth signals and checkpoints. This review examines the G0/G1-to-S-phase transition in cancer, highlighting new in vivo findings.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Cancer is characterized by uncontrolled cell proliferation, a deviation from normal cell cycle regulation.
- Normal cells require external signals for proliferation and adhere to checkpoints, especially in response to DNA damage.
- Cancer cells often evade these regulatory mechanisms, leading to continuous growth.
Purpose of the Study:
- To review the current understanding of cell cycle dysregulation at the G0/G1-to-S-phase transition in cancer.
- To emphasize recent in vivo studies that challenge existing models of cell cycle control in cancer development and tumorigenesis.
Main Methods:
- This is a review article, summarizing existing research.
- Focus on in vivo studies investigating cell cycle regulation in cancer.
- Analysis of G0/G1-to-S-phase transition mechanisms.
Main Results:
- Cancer cells proliferate unchecked, independent of normal mitogenic signals and stromal influences.
- They bypass proliferation-inhibitory signals associated with differentiation and growth factor dependence.
- Cancer cells often evade cell cycle arrest mechanisms triggered by DNA damage or other physiological insults.
Conclusions:
- Dysregulation of the G0/G1-to-S-phase transition is a key feature of cancer.
- In vivo evidence necessitates a re-evaluation of current models of cell cycle control in tumorigenesis.
- Understanding these dysregulations is crucial for developing targeted cancer therapies.